Literature DB >> 3582901

Impaired androgen 16 alpha-hydroxylation in hepatic microsomes from carbon tetrachloride-cirrhotic male rats.

M Murray, L Zaluzny, G C Farrell.   

Abstract

Hepatic cirrhosis produced by repeated inhalation of carbon tetrachloride is associated with reduced levels of microsomal cytochrome P450. In this study the C19-steroids androstenedione and testosterone were used as specific probes of the functional activity of several forms of cytochrome P450 in microsomal fractions from control and cirrhotic rat liver. The principal finding, that androstenedione 16 alpha-hydroxylation and testosterone 2 alpha-, 16 alpha-, and 17 alpha-hydroxylation were reduced to 14%-38% of control activity, strongly suggests that levels of the male sexually differentiated cytochrome P450 (P(450)16 alpha) are decreased in hepatic cirrhosis. The activity of other cytochrome P450-mediated C19-steroid hydroxylases, with the exception of androstenedione 6 beta-hydroxylase, appeared essentially unaltered in microsomes from cirrhotic rats. Cirrhosis induced by carbon tetrachloride was also associated with greatly decreased activity of the microsomal cytochrome P450-independent 17 beta-oxidoreductase, an enzyme that catalyzes the conversion of androstenedione to testosterone. Consequently, and in view of the impaired activity of cytochrome P450-mediated testosterone 17 alpha-hydroxylation, the capacity of cirrhotic microsomes to catalyze the interconversion of androstenedione and testosterone was much lower than that of control microsomes. The present data confirm and extend earlier observations that selective impairment of drug oxidation pathways occurs in hepatic cirrhosis. These changes are unrelated to the acute toxicity produced by carbon tetrachloride exposure. The available evidence supports the assertion that specific forms of cytochrome P450 are subject to altered regulation in cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3582901     DOI: 10.1016/0016-5085(87)90326-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

Review 1.  Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.

Authors:  Michael Murray; Fanfan Zhou
Journal:  Br J Pharmacol       Date:  2017-04-24       Impact factor: 8.739

2.  Differential regulation of endobiotic-oxidizing cytochromes P450 in vitamin A-deficient male rat liver.

Authors:  M Murray; R M Sefton; K D Croft; A M Butler
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  The ixabepilone and vandetanib combination shows synergistic activity in docetaxel-resistant MDA-MB-231 breast cancer cells.

Authors:  Stanton Tam; Yassir Al-Zubaidi; Md Khalilur Rahman; Kirsi Bourget; Fanfan Zhou; Michael Murray
Journal:  Pharmacol Rep       Date:  2022-07-30       Impact factor: 3.919

4.  Downregulation of the male-specific hepatic microsomal steroid 16 alpha-hydroxylase, cytochrome P-450UT-A, in rats with portal bypass. Relevance to estradiol accumulation and impaired drug metabolism in hepatic cirrhosis.

Authors:  E Cantrill; M Murray; I Mehta; G C Farrell
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

Review 5.  P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease.

Authors:  M Murray
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.